Abstract
Clarifying the underlying biology of BPD, including the etiological mechanisms, genetic factors, and pathological processes is essential for a full understanding of the disorder and provides a basis for the development of more effective treatment intervention and preventive strategies (Beauchaine, Hong, & Marsh, 2008; Chanen & Kaess, 2012). Over the past two decades, neurobiological studies in adult BPD have made important strides, but inquiry into adolescent-onset BPD is still in its infancy. This chapter will review findings in populations both of adult and adolescent-onset BPD pertaining to genetics, oxytocin, opioids, neuroendocrine measures, evoked potentials and neuroimaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balanzá-MartÃnez, V., Rubio, C., Selva-Vera, G., Martinez-Aran, A., Sánchez-Moreno, J., Salazar-Fraile, J., et al. (2008). Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: A systematic review. Neuroscience and Biobehavioral Reviews, 32(8), 1426–1438. doi:10.1016/j.neubiorev.2008.05.019.
Bartz, J., Simeon, D., Hamilton, H., Kim, S., Crystal, S., Braun, A., et al. (2011). Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience, 6(5), 556–563. doi:10.1093/scan/nsq085.
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011). Social effects of oxytocin in humans: Context and person matter. Trends in Cognitive Science, 15(7), 301–309. doi:10.1016/j.tics.2011.05.002.
Bateman, A., & Fonagy, P. (2010). Mentalization based treatment for borderline personality disorder. World Psychiatry, 9(1), 11–15.
Beauchaine, T. P., Hong, J., & Marsh, P. (2008). Sex differences in autonomic correlates of conduct problems and aggression. Journal of the American Academy of Child and Adolescent Psychiatry, 47(7), 788–796. doi:10.1097/CHI.Ob013e318172ef4b.
Bernstein, D. P., Cohen, P., Velez, C. N., Schwab-Stone, M., Siever, L. J., & Shinsato, L. (1993). Prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents. The American Journal of Psychiatry, 150(8), 1237–1243.
Bos, P. A., Panksepp, J., Bluthe, R. M., & van Honk, J. (2012). Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: A review of single administration studies. Frontiers in Neuroendocrinology, 33(1), 17–35. doi:10.1016/j.yfrne.2011.01.002.
Brambilla, P., Soloff, P. H., Sala, M., Nicoletti, M. A., Keshavan, M. S., & Soares, J. C. (2004). Anatomical MRI study of borderline personality disorder patients. Psychiatry Research, 131(2), 125–133. doi:10.1016/j.pscychresns.2004.04.003.
Brunner, R., Henze, R., Parzer, P., Kramer, J., Feigl, N., Lutz, K., et al. (2010). Reduced prefrontal and orbitofrontal gray matter in female adolescents with borderline personality disorder: Is it disorder specific? NeuroImage, 49(1), 114–120. doi:10.1016/j.neuroimage.2009.07.070.
Burket, R. C., & Myers, W. C. (1995). Axis I and personality comorbidity in adolescents with conduct disorder. The Bulletin of the American Academy of Psychiatry and the Law, 23(1), 73–82.
Cadoret, R. J., Langbehn, D., Caspers, K., Troughton, E. P., Yucuis, R., Sandhu, H. K., et al. (2003). Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Comprehensive Psychiatry, 44(2), 88–101. doi:10.1053/comp.2003.50018.
Carrasco, J. L., DÃaz-Marsá, M., Pastrana, J. I., Molina, R., Brotons, L., López-Ibor, M. I., et al. (2007). Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features. The British Journal of Psychiatry, 190, 357–358. doi:10.1192/bjp.bp.106.022590.
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science (New York, N.Y.), 301(5631), 386–389. doi:10.1126/science.1083968.
Ceballos, N. A., Houston, R. J., Hesselbrock, V. M., & Bauer, L. O. (2006). Brain maturation in conduct disorder versus borderline personality disorder. Neuropsychobiology, 53(2), 94–100. doi:10.1159/000092217.
Chanen, A. M., Jackson, H. J., McCutcheon, L. K., Jovev, M., Dudgeon, P., Yuen, H. P., et al. (2008). Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: Randomized controlled trial. The British Journal of Psychiatry, 193(6), 477–484. doi:10.1192/bjp.bp.107.048934.
Chanen, A. M., Jackson, H. J., McGorry, P. D., Allot, K. A., Clarkson, V., & Yuen, H. P. (2004). Two-year stability of personality disorder in older adolescent outpatients. Journal of Personality Disorders, 18(6), 526–541. doi:10.1521/pedi.18.6.526.54798.
Chanen, A. M., & Kaess, M. (2012). Developmental pathways to borderline personality disorder. Current Psychiatry Report, 14(1), 45–53. doi:10.1007/s11920-011-0242-y.
Chanen, A. M., Velakoulis, D., Carison, K., Gaunson, K., Wood, S. J., Yuen, H. P., et al. (2008). Orbitofrontal, amygdala and hippocampal volumes in teenagers with first-presentation borderline personality disorder. Psychiatry Research, 163(2), 116–125. doi:10.1016/j.pscychresns.2007.08.007.
Coccaro, E. F., McCloskey, M. S., Fitzgerald, D. A., & Phan, K. L. (2007). Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biological Psychiatry, 62(2), 168–178. doi:10.1016/j.biopsych.2006.08.024.
Collins, F. S., Brooks, L. D., & Chakravarti, A. (1998). A DNA polymorphism discovery resource for research on human genetic variation. Genome Research, 8(12), 1229–1231.
Crawford, T. N., Cohen, P., First, M. B., Skodol, A. E., Johnson, J. G., & Kasen, S. (2008). Comorbid Axis I and Axis II disorders in early adolescence: Outcomes 20 years later. Archives of General Psychiatry, 65(6), 641–648. doi:10.1001/archpsyc.65.6.641.
da Rocha, F. F., Malloy-Diniz, L., de Sousa, K. C. A., Prais, H. A. C., Correa, H., & Teixeira, A. L. (2008). Borderline personality features possibly related to cingulate and orbitofrontal cortices dysfunction due to schizencephaly. Clinical Neurology and Neurosurgery, 110(4), 396–399. doi:10.1016/j.clineuro.2007.12.009.
Distel, M. A., Middeldorp, C. M., Trull, T. J., Derom, C. A., Willemsen, G., & Boomsma, D. I. (2011). Life events and borderline personality features: The influence of gene-environment interaction and gene-environment correlation. Psychological Medicine, 41(4), 849–860. doi:10.1017/S0033291710001297.
Donegan, N. H., Sanislow, C. A., Blumberg, H. P., Fulbright, R. K., Lacadie, C., Skudlarski, P., et al. (2003). Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biological Psychiatry, 54(11), 1284–1293.
Driessen, M., Herrmann, J., Stahl, K., Zwaan, M., Meier, S., Hill, A., et al. (2000). Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry, 57(12), 1115–1122.
Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., et al. (2006). Introducing MASC: A movie for the assessment of social cognition. Journal of Autism and Developmental Disorders, 36(5), 623–636. doi:10.1007/s10803-006-0107-0.
Dziobek, I., Preissler, S., Grozdanovic, Z., Heuser, I., Heekeren, H. R., & Roepke, S. (2011). Neuronal correlates of altered empathy and social cognition in borderline personality disorder. NeuroImage, 57(2), 539–548. doi:10.1016/j.neuroimage.2011.05.005.
Eisenberg, N., & Miller, P. A. (1987). The relation of empathy to prosocial and related behaviors. Psychological Bulletin, 101(1), 91–119.
Frankle, W. G., Lombardo, I., New, A. S., Goodman, M., Talbot, P. S., Huang, Y., et al. (2005). Brain serotonin transporter distribution in subjects with impulsive aggressivity: A positron emission study with [11C]McN 5652. The American Journal of Psychiatry, 162(5), 915–923. doi:10.1176/appi.ajp.162.5.915.
Garner, B., Chanen, A. M., Phillips, L., Velakoulis, D., Wood, S. J., Jackson, H. J., et al. (2007). Pituitary volume in teenagers with first-presentation borderline personality disorder. Psychiatry Research: Neuroimaging, 156(3), 257–261.
Goodman, M., Hazlett, E. A., Avedon, J. B., Siever, D. R., Chu, K.-W., & New, A. S. (2011). Anterior cingulate volume reduction in adolescents with borderline personality disorder and co-morbid major depression. Journal of Psychiatric Research, 45(6), 803–807. doi:10.1016/j.jpsychires.2010.11.011.
Goodman, M., New, A. S., Triebwasser, J., Collins, K. A., & Siever, L. (2010). Phenotype, endophenotype, and genotype comparisons between borderline personality disorder and major depressive disorder. Journal of Personality Disorders, 24(1), 38–59. doi:10.1521/pedi.2010.24.1.38.
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. The American Journal of Psychiatry, 160(4), 636–645.
Grilo, C. M., Becker, D. F., Fehon, D. C., Walker, M. L., Edell, W. S., & McGlashan, T. H. (1996). Gender differences in personality disorders in psychiatrically hospitalized adolescents. The American Journal of Psychiatry, 153(8), 1089–1091.
Grossman, R., Yehuda, R., New, A., Schmeidler, J., Silverman, J., Mitropoulou, V., et al. (2003). Dexamethasone suppression test findings in subjects with personality disorders: Associations with posttraumatic stress disorder and major depression. The American Journal of Psychiatry, 160(7), 1291–1298.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., et al. (2010). Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry, 67(7), 692–694.
Guastella, A. J., & MacLeod, C. (2012). A critical review of the influence of oxytocin nasal spray on social cognition in humans: Evidence and future directions. Hormones and Behavior, 61(3), 410–418. doi:10.1016/j.yhbeh.2012.01.002.
Hankin, B. L., Barrocas, A. L., Jenness, J., Oppenheimer, C. W., Badanes, L. S., Abela, J. R. Z., et al. (2011). Association between 5-HTTLPR and borderline personality disorder traits among youth. Frontiers in Psychiatry/Frontiers Research Foundation, 2, 6. doi:10.3389/fpsyt.2011.00006.
Hazlett, E. A., New, A. S., Newmark, R., Haznedar, M. M., Lo, J. N., Speiser, L. J., et al. (2005). Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biological Psychiatry, 58(8), 614–623. doi:10.1016/j.biopsych.2005.04.029.
Hazlett, E. A., Speiser, L. J., Goodman, M., Roy, M., Carrizal, M., Wynn, J. K., et al. (2007). Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder. Biological Psychiatry, 62(3), 250–255. doi:10.1016/j.biopsych.2006.10.028.
Hazlett, E. A., Zhang, J., New, A. S., Zelmanova, Y., Goldstein, K. E., Haznedar, M. M., et al. (2012). Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biological Psychiatry, 72(6), 448–456.
Houston, R. J., Bauer, L. O., & Hesselbrock, V. M. (2004). Effects of borderline personality disorder features and a family history of alcohol or drug dependence on P300 in adolescents. International Journal of Psychophysiology, 53(1), 57–70.
Houston, R. J., Ceballos, N. A., Hesselbrock, V. M., & Bauer, L. O. (2005). Borderline personality disorder features in adolescent girls: P300 evidence of altered brain maturation. Clinical Neurophysiology, 116(6), 1424–1432. doi:10.1016/j.clinph.2005.01.013.
Irle, E., Lange, C., & Sachsse, U. (2005). Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biological Psychiatry, 57(2), 173–182. doi:10.1016/j.biopsych.2004.10.004.
Johansson, A., Westberg, L., Sandnabba, K., Jern, P., Salo, B., & Santtila, P. (2012). Associations between oxytocin receptor gene (OXTR) polymorphisms and self-reported aggressive behavior and anger: Interactions with alcohol consumption. Psychoneuroendocrinology, 37(9), 1546–1556. doi:10.1016/j.psyneuen.2012.02.009.
Jovev, M., Garner, B., Phillips, L., Velakoulis, D., Wood, S. J., Jackson, H. J., et al. (2008). An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder. Psychiatry Research: Neuroimaging, 162(3), 273–277.
Kaess, M., Hille, M., Parzer, P., Maser-Gluth, C., Resch, F., & Brunner, R. (2012). Alterations in the neuroendocrinological stress response to acute psychosocial stress in adolescents engaging in nonsuicidal self-injury. Psychoneuroendocrinology, 37(1), 157–161. doi:10.1016/j.psyneuen.2011.05.009.
Kendler, K. S. (1995). Genetic epidemiology in psychiatry. Taking both genes and environment seriously. Archives of General Psychiatry, 52(11), 895–899.
Kendler, K. S., Aggen, S. H., Czajkowski, N., Roysamb, E., Tambs, K., Torgersen, S., et al. (2008). The structure of genetic and environmental risk factors for DSM-IV personality disorders: A multivariate twin study. Archives of General Psychiatry, 65(12), 1438–1446. doi:65/12/1438 [pii].
Kendler, K. S., Myers, J., & Reichborn-Kjennerud, T. (2011). Borderline personality disorder traits and their relationship with dimensions of normative personality: A web-based cohort and twin study. Acta Psychiatrica Scandinavica, 123(5), 349–359. doi:10.1111/j.1600-0447.2010.01653.x.
Lange, C., Kracht, L., Herholz, K., Sachsse, U., & Irle, E. (2005). Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Research, 139(2), 115–126. doi:10.1016/j.pscychresns.2005.05.003.
Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A. S., Mensebach, C., et al. (2005). Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology, 30(9), 919–923. doi:10.1016/j.psyneuen.2005.02.009.
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011). Borderline personality disorder. Lancet, 377(9759), 74–84. doi: S0140-6736(10)61422-5 [pii] 1016/S0140–6736(10)61422–5 [doi].
Lewinsohn, P. M., Rohde, P., Seeley, J. R., & Klein, D. N. (1997). Axis II psychopathology as a function of Axis I disorders in childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 36(12), 1752–1759. doi:10.1097/00004583-199712000-00024.
Leyton, M., Okazawa, H., Diksic, M., Paris, J., Rosa, P., Mzengeza, S., et al. (2001). Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. The American Journal of Psychiatry, 158(5), 775–782.
Lis, S., & Bohus, M. (2013). Social interaction in borderline personality disorder. Current Psychiatry Reports, 15(2), 338. doi:10.1007/s11920-012-0338-z.
Love, T. M., Enoch, M. A., Hodgkinson, C. A., Pecina, M., Mickey, B., Koeppe, R. A., et al. (2012). Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biological Psychiatry, 72(3), 198–206. doi:10.1016/j.biopsych.2012.01.033.
Macdonald, K., & Macdonald, T. M. (2009). The peptide that binds: A systematic review of oxytocin and its prosocial effects in humans. Harvard Review of Psychiatry, 18(1), 1–21.
Mak, A. D., & Lam, L. C. (2013). Neurocognitive profiles of people with borderline personality disorder. Current Opinion in Psychiatry, 26(1), 90–96. doi:10.1097/YCO.0b013e32835b57a9.
Malik, A. I., Zai, C. C., Abu, Z., Nowrouzi, B., & Beitchman, J. H. (2012). The role of oxytocin and oxytocin receptor gene variants in childhood-onset aggression. Genes, Brain, and Behavior, 11(5), 545–551. doi:10.1111/j.1601-183X.2012.00776.x.
Meares, R., Schore, A., & Melkonian, D. (2011). Is borderline personality a particularly right hemispheric disorder? A study of P3a using single trial analysis. The Australian and New Zealand Journal of Psychiatry, 45(2), 131–139. doi:10.3109/00048674.2010.497476.
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011). Oxytocin and vasopressin in the human brain: Social neuropeptides for translational medicine. Nature Reviews Neuroscience, 12(9), 524–538. doi:10.1038/nrn3044.
Minzenberg, M. J., Fan, J., New, A. S., Tang, C. Y., & Siever, L. J. (2007). Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study. Psychiatry Research, 155(3), 231–243. doi:10.1016/j.pscychresns.2007.03.006.
Minzenberg, M. J., Fan, J., New, A. S., Tang, C. Y., & Siever, L. J. (2008). Frontolimbic structural changes in borderline personality disorder. Journal of Psychiatric Research, 42(9), 727–733. doi:10.1016/j.jpsychires.2007.07.015.
New, A. S., Goodman, M., Triebwasser, J., & Siever, L. J. (2008). Recent advances in the biological study of personality disorders. The Psychiatric Clinics of North America, 31(3), 441–461, vii. doi:S0193-953X(08)00035-X [pii].
New, A. S., Hazlett, E. A., Buchsbaum, M. S., Goodman, M., Mitelman, S. A., Newmark, R., et al. (2007). Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology, 32(7), 1629–1640. doi:10.1038/sj.npp.1301283.
New, A. S., Hazlett, E. A., Buchsbaum, M. S., Goodman, M., Reynolds, D., Mitropoulou, V., et al. (2002). Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry, 59(7), 621–629.
New, A. S., & Stanley, B. (2010). An opioid deficit in borderline personality disorder: Self-cutting, substance abuse, and social dysfunction. American Journal of Psychiatry, 167(8), 882–885.
Ni, X., Bismil, R., Chan, K., Sicard, T., Bulgin, N., McMain, S., et al. (2006). Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neuroscience Letters, 408(3), 214–219. doi:10.1016/j.neulet.2006.09.002.
Ni, X., Chan, K., Bulgin, N., Sicard, T., Bismil, R., McMain, S., et al. (2006). Association between serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research, 40(5), 448–453. doi:10.1016/j.jpsychires.2006.03.010.
Ni, X., Chan, D., Chan, K., McMain, S., & Kennedy, J. L. (2009). Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(1), 128–133.
Ni, X., Sicard, T., Bulgin, N., Bismil, R., Chan, K., McMain, S., et al. (2007). Monoamine oxidase A gene is associated with borderline personality disorder. Psychiatric Genetics, 17(3), 153–157.
Paris, J. (2005). The diagnosis of borderline personality disorder: Problematic but better than the alternatives. Annals of Clinical Psychiatry, 17(1), 41–46.
Pascual, J. C., Soler, J., Barrachina, J., Campins, M. J., Alvarez, E., Perez, V., et al. (2008). Failure to detect an association between the serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research, 42(1), 87–88.
Perez-Rodriguez, M. M., Weinstein, S., New, A. S., Bevilacqua, L., Yuan, Q., Zhou, Z., et al. (2010). Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. Journal of Psychiatric Research, 44(15), 1075–1081. doi:10.1016/j.jpsychires.2010.03.014.
Plomin, R., Owen, M. J., & McGuffin, P. (1994). The genetic basis of complex human behaviors. Science (New York, N.Y.), 264(5166), 1733–1739.
Prossin, A. R., Love, T. M., Koeppe, R. A., Zubieta, J. K., & Silk, K. R. (2010). Dysregulation of regional endogenous opioid function in borderline personality disorder. American Journal of Psychiatry, 167(8), 925–933.
Ragnauth, A. K., Devidze, N., Moy, V., Finley, K., Goodwillie, A., Kow, L. M., et al. (2005). Female oxytocin gene-knockout mice, in a semi-natural environment, display exaggerated aggressive behavior. Genes, Brain, and Behavior, 4(4), 229–239. doi:10.1111/j.1601-183X.2005.00118.x.
Rinne, T., de Kloet, E. R., Wouters, L., Goekoop, J. G., DeRijk, R. H., & van den Brink, W. (2002). Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biological Psychiatry, 52(11), 1102–1112.
Ruocco, A. C., Amirthavasagam, S., Choi-Kain, L. W., & McMain, S. F. (2012). Neural correlates of negative emotionality in borderline personality disorder: An activation-likelihood-estimation meta-analysis. Biological Psychiatry, 73(2), 153–160. doi:10.1016/j.biopsych.2012.07.014.
Rüsch, N., Luders, E., Lieb, K., Zahn, R., Ebert, D., Thompson, P. M., et al. (2007). Corpus callosum abnormalities in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Journal of Psychiatry & Neuroscience, 32(6), 417–422.
Schmahl, C., Bohus, M., Esposito, F., Treede, R.-D., Di Salle, F., Greffrath, W., et al. (2006). Neural correlates of antinociception in borderline personality disorder. Archives of General Psychiatry, 63(6), 659–667. doi:10.1001/archpsyc.63.6.659.
Schmahl, C. G., Vermetten, E., Elzinga, B. M., & Douglas Bremner, J. (2003). Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Research, 122(3), 193–198.
Schnell, K., Dietrich, T., Schnitker, R., Daumann, J., & Herpertz, S. C. (2007). Processing of autobiographical memory retrieval cues in borderline personality disorder. Journal of Affective Disorders, 97(1–3), 253–259. doi:10.1016/j.jad.2006.05.035.
Schuermann, B., Kathmann, N., Stiglmayr, C., Renneberg, B., & Endrass, T. (2011). Impaired decision making and feedback evaluation in borderline personality disorder. Psychological Medicine, 41(9), 1917–1927. doi:10.1017/S003329171000262X.
Sen, S., Villafuerte, S., Nesse, R., Stoltenberg, S. F., Hopcian, J., Gleiberman, L., et al. (2004). Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biological Psychiatry, 55(3), 244–249.
Sharp, C., Pane, H., Ha, C., Venta, A., Patel, A. B., Sturek, J., et al. (2011). Theory of mind and emotion regulation difficulties in adolescents with borderline traits. Journal of the American Academy of Child and Adolescent Psychiatry, 50(6), 563–573 e561. doi:10.1016/j.jaac.2011.01.017.
Sher, L., & Stanley, B. H. (2009). Biological models of nonsuicidal self-injury. In M. K. Nock (Ed.), Understanding nonsuicidal self-injury: Origins, assessment and treatment. Washington, DC: American Psychological Association.
Siegle, G. J. (2007). Brain mechanisms of borderline personality disorder at the intersection of cognition, emotion, and the clinic. The American Journal of Psychiatry, 164(12), 1776–1779. doi:10.1176/appi.ajp.2007.07091505.
Siever, L. J., Buchsbaum, M. S., New, A. S., Spiegel-Cohen, J., Wei, T., Hazlett, E. A., et al. (1999). d, l-Fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology, 20(5), 413–423. doi:10.1016/S0893-133X(98)00111-0.
Silbersweig, D., Clarkin, J. F., Goldstein, M., Kernberg, O. F., Tuescher, O., Levy, K. N., et al. (2007). Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. The American Journal of Psychiatry, 164(12), 1832–1841. doi:10.1176/appi.ajp.2007.06010126.
Simeon, D., Bartz, J., Hamilton, H., Crystal, S., Braun, A., Ketay, S., et al. (2011). Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study. Psychoneuroendocrinology, 36(9), 1418–1421. doi:10.1016/j.psyneuen.2011.03.013.
Soloff, P. H., Meltzer, C. C., Becker, C., Greer, P. J., Kelly, T. M., & Constantine, D. (2003). Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Research, 123(3), 153–163.
Soloff, P. H., Price, J. C., Meltzer, C. C., Fabio, A., Frank, G. K., & Kaye, W. H. (2007). 5HT2A receptor binding is increased in borderline personality disorder. Biological Psychiatry, 62(6), 580–587. doi:10.1016/j.biopsych.2006.10.022.
Stanley, B., & Siever, L. J. (2010). The interpersonal dimension of borderline personality disorder: Toward a neuropeptide model. The American Journal of Psychiatry, 167(1), 24–39. doi:appi.ajp.2009.09050744 [pii] 10.1176/appi.ajp.2009.09050744 [doi].
Stoffers, J. M., Vollm, B. A., Rucker, G., Timmer, A., Huband, N., & Lieb, K. (2012). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 8, CD005652. doi:10.1002/14651858.CD005652.pub2.
Tachibana, M., Kagitani-Shimono, K., Mohri, I., Yamamoto, T., Sanefuji, W., Nakamura, A., et al. (2013). Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 23(2), 123–127. doi:10.1089/cap.2012.0048.
Takahashi, T., Chanen, A. M., Wood, S. J., Walterfang, M., Harding, I. H., Yücel, M., et al. (2009). Midline brain structures in teenagers with first-presentation borderline personality disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33(5), 842–846. doi:10.1016/j.pnpbp.2009.03.035.
Takahashi, T., Chanen, A. M., Wood, S. J., Yücel, M., Kawasaki, Y., McGorry, P. D., et al. (2010). Superior temporal gyrus volume in teenagers with first-presentation borderline personality disorder. Psychiatry Research, 182(1), 73–76. doi:10.1016/j.pscychresns.2009.10.014.
Takahashi, T., Chanen, A. M., Wood, S. J., Yücel, M., Tanino, R., Suzuki, M., et al. (2009). Insular cortex volume and impulsivity in teenagers with first-presentation borderline personality disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33(8), 1395–1400. doi:10.1016/j.pnpbp.2009.07.017.
Torgersen, S. (2000). Genetics of patients with borderline personality disorder. The Psychiatric Clinics of North America, 23(1), 1–9.
Tost, H., Kolachana, B., Hakimi, S., Lemaitre, H., Verchinski, B. A., Mattay, V. S., et al. (2010). A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proceedings of the National Academy of Sciences of the United States of America, 107(31), 13936–13941. doi:10.1073/pnas.1003296107.
Walter, M., Bureau, J.-F., Holmes, B. M., Bertha, E. A., Hollander, M., Wheelis, J., et al. (2008). Cortisol response to interpersonal stress in young adults with borderline personality disorder: A pilot study. European Psychiatry, 23(3), 201–204. doi:10.1016/j.eurpsy.2007.12.003.
Walterfang, M., Chanen, A. M., Barton, S., Wood, A. G., Jones, S., Reutens, D. C., et al. (2010). Corpus callosum morphology and relationship to orbitofrontal and lateral ventricular volume in teenagers with first-presentation borderline personality disorder. Psychiatry Research: Neuroimaging, 183(1), 30–37.
Whittle, S., Chanen, A. M., Fornito, A., McGorry, P. D., Pantelis, C., & Yücel, M. (2009). Anterior cingulate volume in adolescents with first-presentation borderline personality disorder. Psychiatry Research, 172(2), 155–160. doi:10.1016/j.pscychresns.2008.12.004.
Wilson, S. T., Stanley, B., Brent, D. A., Oquendo, M. A., Huang, Y., & Mann, J. J. (2009). The tryptophan hydroxylase-1 A218C polymorphism is associated with diagnosis, but not suicidal behavior, in borderline personality disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 150B(2), 202–208. doi:10.1002/ajmg.b.30788.
Wong, A. H. C., Gottesman, I. I., & Petronis, A. (2005). Phenotypic differences in genetically identical organisms: The epigenetic perspective. Human Molecular Genetics, 14 Spec No 1, R11–R18. doi:10.1093/hmg/ddi116.
Wu, N., Li, Z., & Su, Y. (2012). The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy. Journal of Affective Disorders, 138(3), 468–472. doi:10.1016/j.jad.2012.01.009.
Zaboli, G., Gizatullin, R., Nilsonne, A., Wilczek, A., Jönsson, E. G., Ahnemark, E., et al. (2006). Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology, 31(9), 1982–1990. doi:10.1038/sj.npp.1301046.
Zanetti, M. V., Soloff, P. H., Nicoletti, M. A., Hatch, J. P., Brambilla, P., Keshavan, M. S., et al. (2007). MRI study of corpus callosum in patients with borderline personality disorder: A pilot study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31(7), 1519–1525. doi:10.1016/j.pnpbp.2007.07.013.
Zetzsche, T., Frodl, T., Preuss, U. W., Schmitt, G., Seifert, D., Leinsinger, G., et al. (2006). Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biological Psychiatry, 60(3), 302–310. doi:10.1016/j.biopsych.2005.11.020.
Zetzsche, T., Preuss, U. W., Frodl, T., Schmitt, G., Seifert, D., Münchhausen, E., et al. (2007). Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Research, 154(2), 157–170. doi:10.1016/j.pscychresns.2006.05.010.
Zink, C. F., & Meyer-Lindenberg, A. (2012). Human neuroimaging of oxytocin and vasopressin in social cognition. Hormones and Behavior, 61(3), 400–409. doi:10.1016/j.yhbeh.2012.01.016.
Recommended Reading
Chanen, A. M., & Kaess, M. (2012). Developmental pathways to borderline personality disorder. Current Psychiatry Report, 14(1), 45–53. doi: 10.1007/s11920-011-0242-y.
Kendler, K. S., Aggen, S. H., Czajkowski, N., Roysamb, E., Tambs, K., Torgersen, S., et al. (2008). The structure of genetic and environmental risk factors for DSM-IV personality disorders: A multivariate twin study. Archives of General Psychiatry, 65(12), 1438–1446. doi: 65/12/1438 [pii].
New, A. S., Goodman, M., Triebwasser, J., & Siever, L. J. (2008). Recent advances in the biological study of personality disorders. The Psychiatric Clinics of North America, 31(3), 441–461, vii. doi: S0193-953X(08)00035-X [pii].
Ruocco, A. C., Amirthavasagam, S., Choi-Kain, L. W., & McMain, S. F. (2012). Neural correlates of negative emotionality in borderline personality disorder: An activation-likelihood-estimation meta-analysis. Biological Psychiatry, 73(2), 153–160. doi:10.1016/j.biopsych.2012.07.014.
Stanley, B., & Siever, L. J. (2010). The interpersonal dimension of borderline personality disorder: Toward a neuropeptide model. The American Journal of Psychiatry, 167(1), 24–39. doi: appi.ajp.2009.09050744 [pii] 10.1176/appi.ajp.2009.09050744 [doi].
Acknowledgments
This research is supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Veterans Affairs James J Peters VAMC, and the Department of Veterans Affairs NY/NJ (VISN3) Mental Illness Research, Education, and Clinical Center (MIRECC).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Goodman, M., Perez-Rodriguez, M.M., Siever, L. (2014). The Neurobiology of Adolescent-Onset Borderline Personality Disorder. In: Sharp, C., Tackett, J. (eds) Handbook of Borderline Personality Disorder in Children and Adolescents. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0591-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0591-1_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0590-4
Online ISBN: 978-1-4939-0591-1
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)